Adial Pharmaceuticals Inc ADIL

Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
Benzinga
·
Jul 12, 2023 05:59
1min
Adial Pharmaceuticals (ADIL.US)
1.130
2.250
+0.00%
+99.12%

Brookline Capital analyst Kumaraguru Raja reiterates Adial Pharmaceuticals (NASDAQ:ADIL) with a Buy and maintains $6 price target.

Disclaimer

I in 0.47 nice drop to buy

I’m out. I’ll buy back @ 0.05

Dang!! I’m down like a mofo. I’m just gonna ride it out at this point.

Pump and dump, this is bs.. column is above average and it still ?. Be careful boys and girls, I smell crash.

$ADIL WTF ?

Pump and dump. No institutional investors, BNGO has better system for genetics, no clue what is the future in here , except some guys trying to get my money. Br careful! Check charts !

$ICON https://www.iconixbrand.com only 11M float. Big brands under the umbrella. Umbro is in Walmart. New licensing agreement for MUDD. Trading under $1.00

This is such an annoying stock. But I’ll wait until 3 bucks then I’m out.

Thank God I just dabbled in this one. I broke one of my own rules and bet on pharmaceuticals. Won’t happen again.